These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19405205)

  • 1. Botulinum toxin for trigeminal neuralgia.
    Nurmikko T; Cruccu G
    Eur J Neurol; 2009 May; 16(5):e104. PubMed ID: 19405205
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin for trigeminal neuralgia--do we have the evidence?
    Zakrzewska JM
    Cephalalgia; 2012 Nov; 32(15):1154-5; author reply 1156-7. PubMed ID: 22990690
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin and intractable trigeminal neuralgia.
    Türk U; Ilhan S; Alp R; Sur H
    Clin Neuropharmacol; 2005; 28(4):161-2. PubMed ID: 16062093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin in trigeminal neuralgia.
    Castillo-Álvarez F; Hernando de la Bárcena I; Marzo-Sola ME
    Med Clin (Barc); 2017 Jan; 148(1):28-32. PubMed ID: 27743594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.
    Bohluli B; Motamedi MH; Bagheri SC; Bayat M; Lassemi E; Navi F; Moharamnejad N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):47-50. PubMed ID: 20674409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Toxin Type A Injections as an Effective Treatment of Refractory Multiple Sclerosis-Related Trigeminal Pain - A Case Report.
    Calejo M; Salgado P; Moreira B; Correia C; Barros J
    Headache; 2019 Sep; 59(8):1379-1381. PubMed ID: 31424566
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trigeminal neuralgia: treatment options for refractory cases].
    Ruscheweyh R; Straube A
    MMW Fortschr Med; 2019 May; 161(10):52-56. PubMed ID: 31129820
    [No Abstract]   [Full Text] [Related]  

  • 8. BoTN-A: The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses.
    Br Dent J; 2016 Oct; 221(8):475. PubMed ID: 27767141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trigeminal Neuralgia With Extraoral Trigger Zone Successfully Treated With Intraoral Injections of Botulinum Toxin: A Case Report.
    Dinan JE; Smith A; Hawkins JM
    Clin Neuropharmacol; 2020; 43(5):162-163. PubMed ID: 32947428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
    Zúñiga C; Díaz S; Piedimonte F; Micheli F
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):500-3. PubMed ID: 18813708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of botulinum toxin type a for patients with painful tic convulsif.
    Micheli F; Scorticati MC; Raina G
    Clin Neuropharmacol; 2002; 25(5):260-2. PubMed ID: 12410057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A.
    Guardiani E; Sadoughi B; Blitzer A; Sirois D
    Laryngoscope; 2014 Feb; 124(2):413-7. PubMed ID: 23818108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses.
    Shackleton T; Ram S; Black M; Ryder J; Clark GT; Enciso R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jul; 122(1):61-71. PubMed ID: 27260275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin - intraorally: Intraoral administration of botulinum toxin for trigeminal neuropathic pain.
    Br Dent J; 2016 Aug; 221(3):126. PubMed ID: 27514346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials.
    Wei J; Zhu X; Yang G; Shen J; Xie P; Zuo X; Xia L; Han Q; Zhao Y
    Brain Behav; 2019 Oct; 9(10):e01409. PubMed ID: 31541518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral hemifacial spasm and trigeminal neuralgia: a unique form of painful tic convulsif.
    Felicio AC; Godeiro Cde O; Borges V; Silva SM; Ferraz HB
    Mov Disord; 2007 Jan; 22(2):285-6. PubMed ID: 17083101
    [No Abstract]   [Full Text] [Related]  

  • 18. Comment on AAN-EFNS guidelines on trigeminal neuralgia management.
    Teive HA; Piovesan EJ; Kowacs PA; Munhoz RP; Werneck LC
    Eur J Neurol; 2009 May; 16(5):e105. PubMed ID: 19405206
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia.
    Liu J; Xu YY; Zhang QL; Luo WF
    Pain Res Manag; 2018; 2018():7365148. PubMed ID: 29849847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
    Wu CJ; Lian YJ; Zheng YK; Zhang HF; Chen Y; Xie NC; Wang LJ
    Cephalalgia; 2012 Apr; 32(6):443-50. PubMed ID: 22492424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.